Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for GRANULES
Revenue projections for GRANULES

Granules India Limited's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio 1.55500
forwardPE 14.77587
debtToEquity 39.15300
earningsGrowth 0.17300
revenueGrowth 0.01800
grossMargins 0.58582
operatingMargins 0.15991
trailingEps 20.69000
forwardEps 0.00000

GRANULES's current ratio, being 1.555, demonstrates that the company has the liquidity necessary to service its short-term debt. With strong cash reserves and current assets, GRANULES is well-equipped to meet its immediate financial obligations without any difficulties.
GRANULES's Forward PE is well-positioned, indicating the stock price is favorable compared to its earnings. This suggests the stock is not overpriced and offers room for growth, making it an attractive option for investors looking for future value appreciation.

Price projections:

Price projections for GRANULES
Price projections for GRANULES

The gradual downward revision of GRANULES's price projections signals decreasing confidence in the company's future performance. Analysts are adjusting their expectations, reflecting uncertainty about GRANULES's growth potential.

Recommendation changes over time:

Recommendations trend for GRANULES
Recommendations trend for GRANULES


Analysts' buy bias for GRANULES signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to GRANULES, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.